Manganese: A transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of Parkinsonism

Neuroscience

Volumn 85, Issue 4, 1998, Pages 1101-1111

  Sziraki I ^a   Mohanakumar, K P ^a   Rauhala, P ^a   Kim, H G ^a   Yeh, K J ^a   Chiueh, C C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Dopamine; Ferrous citrate; Hydroxyl radical; Lipid peroxidation; Parkinson's disease; Substantia nigra

Indexed keywords

MANGANESE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOPAMINE BRAIN LEVEL; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CAUDATE NUCLEUS; DOPAMINE; HYDROXYL RADICAL; IRON; LIPID PEROXIDATION; MALE; MANGANESE; MESENCEPHALON; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE;

EID: 0032144780     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00660-X     Document Type: Article

References (75)

1. 3+. Neurodegeneration 4, 329-334.
2. 2. Aruoma O., Halliwell B., Laughton M. J., Quinlan G. J. and Gutteridge J. M. C. (1989) The mechanism of initiation of lipid peroxidation: evidence against a requirement for an iron(II) - iron(III) complex. Biochem. J. 258, 617-620.
3. 3. Barbeau A. (1984) Manganese and extrapyramidal disorders. Neurotoxicology 5, 13-16.
4. 4. Beuter A., Mergler D., de Geoffroy A., Carriere L., Belanger S., Varghese L., Sreekumar J. and Gauthier S. (1994) Diadochokinesimetry: a study of patients with Parkinson's disease and manganese exposed workers. Neurotoxicology 15, 655-664.
5. 5. Brouillet E. P., Shinobu L., McGarvey U., Hochberg F. and Beal M. F. (1993) Manganese injection into rat striatum produces excitatotoxic lesions by impairing energy metabolism. Expl Neurol. 120, 89-94.
6. 6. Burcher J. R., Tien M., Morehouse L. A. and Aust S. D. (1983) Redox cycling and lipid peroxidation: the central role of iron chelates. Fundam. appl. Toxic. 3, 222-226.
7. 7. Butterworth R. F., Spahr L., Fontaine S. and Layrarques G. P. (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab. Brain Dis. 10, 259-267.
8. 8. Carl G. F., Blackwell L. K., Barnett F. C., Thompson J. L., Rissinger C. J., Olin K. L., Critchfield J. W., Keen C. L. and Gallagher B. B. (1993) Manganese and epilepsy: brain glutamine synthetase and liver arginase activities in genetically epilepsy prone and chronically seizured rats. Epilepsia 34, 441-446.
9. 9. Cavallini L., Valente M. and Bindoli A. (1984) On the mechanism of inhibition of lipid peroxidation by manganese. Inorg. Chim. Acta 91, 117-120.
10. 10. Chandra S. V. and Shukla G. S. (1981) Concentrations of striatal catecholamines in rats given manganese chloride through drinking water. J. Neurochem. 36, 683-687.
11. 11. Chandra S. V. (1983) Psychiatric illness due to manganese poisoning. Acta psychiat. scand. 303 Suppl., 49-54.
12. +. Free Radic. biol. Med. 13, 581-583.
13. 13. Chiueh C. C., Miyake H. and Peng M. T. (1993) Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanism involved in MPTP-induced parkinsonism. Adv. Neurol. 60, 251-258.
14. 14. Chiueh C. C., Murphy D. L., Miyake H., Lang K., Tulsi P. K. and Huang S.-J. (1993) Hydroxyl free radical (•OH) formation reflected by salicylate hydroxylation and neuromelanin: in vivo markers for oxidative injury of nigral neurons. Ann. N. Y. Acad. Sci. 679, 370-375.
15. 15. Chiueh C. C., Zukowska-Grojec Z., Kirk K. L. and Kopin I. J. (1983) 6-Fluorocatecholamines as false adrenergic neurotransmitters. J. Pharmac. exp. Ther. 225, 529-533.
16. 16. Ciuffi M., Gentilini G., Franchi-Micheli S. and Zilletti L. (1991) Lipid peroxidation induced "in vivo" by iron-carbohydrate complex in rat brain cortex. Neurochem. Res. 16, 43-49.
17. 17. Coassin M., Ursini F. and Bindoli A. (1992) Antioxidant effect of manganese. Archs Biochem. Biophys. 299, 330-333.
18. 18. Commissiong J. W., Slimowitch C. and Toffano G. (1990) Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Br. J. Pharmac. 99, 741-749.
19. 19. Cortzias G. C., Papavasiliou P. S., Ginos J., Steck A. and Duby S. (1971) Metabolic modification of Parkinson's disease and chronic manganese poisoning. A. Rev. Med. 22, 305-326.
20. 20. Daniels A. J. and Abarca J. (1991) Effect of intranigral manganese on striatal and nigral synthesis and levels of dopamine and cofactor. Neurotoxicol. Teratol. 13, 483-487.
21. 21. de Rosa G., Keen C. L., Leach R. M. and Hurley L. S. (1980) Regulation of Superoxide dismutase activity. J. Nutr. 110, 795-803.
22. 22. Desole M. S., Miele M., Esposito G., Migheli R., Fresu L., de Natale G. and Miele E. (1994) Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese. Archs Toxicol. 68, 566-570.
23. 23. Devenyi A. G., Barren T. F. and Mamourian A. C. (1994) Dystonia. hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 106, 1068-1071.
24. 24. Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P., Marsden C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953-1975.
25. 25. Donaldson J., McGregor D. and LaBella F. S. (1982) Manganese neurotoxicity: a model for free radical mediated neurodegeneration. Can. J. Physiol. Pharmac. 60, 1398-1405.
26. 26. Donaldson J., LaBella F. S. and Gesser D. (1984) Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology 5, 53-64.
27. 27. Donaldson J. (1987) The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8, 451-462.
28. 28. Eriksson H., Lenngren S. and Heilbronn E. (1987) Effect of long-tern administration of manganese on biogenic amine levels in discrete striatal regions of rat brain. Archs Toxicol. 59, 426-431.
29. 29. Eriksson H., Tedroff J. Thuomas K. A., Aguilonius S. M., Hartvig P., Fasth K. J., Bjurling P., Langstrom B., Hedstrom K. G. and Heilbronn E. (1992) Manganese induced brain lesions in Macaca fasicularis as revealed by positron emission tomography and magnetic resonance imaging. Archs Toxicol. 66, 403-407.
30. 30. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
31. 31. Fridovich I. (1993) Superoxide radical and Superoxide dismutase. A. Rev. Biochem. 64, 97-112.
32. 32. Gerlach M., Ben-Shachar D., Riederer P. and Youdim M. B. (1994) Are brain metabolism of iron as a cause of neurodegenerative disease? J. Neurochem. 63, 793-807.
33. 33. Graham D. G. (1984) Catecholamine toxicity; a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5, 83-95.
34. 34. Hall E. D. (1991) Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders. Ann. Neurol. 32 Suppl., S137-S142.
35. 35. Halliwell B. and Gutteridge J. M. C. (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219, 1-14.
36. 36. Halliwell B. and Gutteridge J. M. C. (1989) Free Radicals in Biology and Medicine. Calderon Press, Oxford.
37. 37. Hill J. M. (1988) The distribution of iron in the brain. In Brain Iron Chemical and Behavioural Aspects (ed. Youdim M. B. H.), pp. 1-24. Taylor and Francis, London.
38. 38. Hirsche E. C., Brandel J. P., Galle P., Javoy-Agid F, and Agid Y. (1991) Iron and alumina increase in substantia nigra of patients with Parkinson's disease: an x-ray microanalysis. J. Neurochem. 56, 446-151.
39. 39. Hong J. S., Hung C. C., Seth P. K., Mason G. and Bondy S. C. (1984) Effect of manganese treatment on the levels of neurotransmitters, hormones, and neuropeptides: modulation by stress. Environ. Res. 34, 242-249.
40. 40. Jenner P. and Olanow C. W. (1996) Oxidative stress and pathogenesis of Parkinson's disease. Neurobiology 47 Suppl., S160-S170.
41. 41. Kikugawa K., Kato T., Beppu M. and Hayasaka A, (1989) Fluorescence and cross-linked proteins formed by free radicals and aldehyde specifics generated during lipid peroxidation. Adv. exp. med. Biol. 266, 345-356.
42. 42. Lai C. T., Zuo D. M. and Yu P. H. (1994) Is brain Superoxide dismutase activity increased following chronic treatment with I-deprenyl? J. neural Transm. 41 Suppl., 221-229.
43. 43. Liccione J. J. and Maines M. D. (1988) Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J. Pharmac. exp. Ther. 247, 156-161.
44. 44. Lloyd R. (1995) Mechanism of the manganese-catalyzed autoxidation of dopamine. Chem. Res. Toxicol. 8, 111-116.
45. 45. Lu C.-S., Huang C.-C., Chu N.-S. and Calne D. B. (1994) Levodopa failure in chronic manganism. Neurology 44, 1600-1602.
46. 46. Malecki E. A. and Greger J. L. (1996) Manganese protects against mitochondrial lipid peroxidation in rats fed with high levels of polyunsaturated fatty acids. J. Nutr. 126, 27-33.
47. 2+-dependent lipid peroxidation. Free Radic. Biol. Med. 3, 379-387.
48. 48. Mochizuki H., Imai H., Endo K., Yokomizo K., Murata Y., Hattori N. and Mizuno Y. (1994) Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci. Lett. 168, 252-253.
49. 49. Mohanakumar K. P., De Bartolomeis A., Wu R.-M., Yeh K. J., Sternberger L. M., Peng S.-Y., Murphy D. L. and Chiueh C. C. (1994) Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation. Ann. N. Y. Acad. Sci. 738, 392-399.
50. 50. Nachtman J. P., Delor S. and Brennan E. (1987) Manganese neurotoxicity: effects of varying oxygen tension and EDTA on dopamine auto-oxidation. Neurotoxicology 8, 249-254.
51. 51. Nakamura K., Oliver C. and Stadtman E. R. (1985) Inactivation of glutamine synthetase by a purified rabbit liver microsomal cytochrome p-450 system. Archs Biochem. Biophys. 240, 319-329.
52. 52. Olanow C. W., Good P. F., Sinotoh H., Hewitt K. A., Vingerhoets F., Snow B. J., Beal M. F., Calne D. B. and Perl D. P. (1996) Manganese intoxication in rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 46, 492-198.
53. 53. Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M. and Floyd R. A. (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. natn. Acad. Sci. U.S.A. 87, 5144-5147.
54. 54. Papavasiliou P. S., Kutt H., Miller S. T., Rosal V., Wang Y. Y. and Aronson R. B. (1979) Seizure disorders and trace metals: manganese tissue levels in treated epileptics. Neurology 29, 1466-1473.
55. 55. Parenti M., Rusconi L., Cappabianca V. M., Parati E. A. and Gropetti A. (1988) Role of dopamine in manganese neurotoxicity. Brain Res. 473, 236-240.
56. 56. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn, Academic, San Diego.
57. 57. Rauhala P., Sziráki I. and Chiueh C. C. (1996) Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl radicals. Free Rad. Biol. Med. 21, 391-394.
58. 58. Rojas P. and Ríos C. (1995) Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-1,2.3,6-tetrahydropyridine neurotoxicity. Neurochem. Res. 20, 1217-1223.
59. 59. Sengstock G. J., Olanow C. W., Menzies R. A., Dunn A. J. and Arendash G. W. (1993) Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers. J. Neurosci. Res. 35, 67-82.
60. 60. Shimasaki H. (1994) Assay of fluorescent lipid peroxidation products. Meth. Enzym. 233, 338-346.
61. 61. Shinotoh H., Snow B. J., Hewitt K. A., Pate B. D., Doudet D., Nugent R., Perl D. P., Olanow W. and Calne D. M. (1995) MRI and PET studies of manganese-intoxicated monkeys. Neurology 45, 1199-1204.
62. 62. Shinotoh H., Snow B. J., Chu N. S., Huang C. C., Lu C. S., Lee C., Takahashi H. and Calne D. B. (1997) Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 48, 1053-1056.
63. 63. Shukla G. S. and Chandra S. V. (1981) Manganese toxicity: lipid peroxidation in rat brain. Acta Pharmac. Toxicol. 48, 95-100.
64. 64. Sloot W. N., Korf J., Koster J. F., DeWit L. E. and Gramsgergen J. B. (1996) Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Expl Neurol. 138, 236-245.
65. 65. Stadtman E. R. and Whittenberger M. E. (1985) Inactivation of Escherichia coli glutamine synthetase by xanthine oxidase, nicotinate hydroxylase, horseradish peroxidase, or glucose oxidase: effects of ferredoxin, putidaredoxin and menadione. Archs Biochem. Biophys. 239, 379-387.
66. +. J. neural Transm. 74, 75-86.
67. 67. Sziráki I., Rauhala P. and Chiueh C. C. (1995) Novel protective effect of manganese against ferrous citrate-induced lipid peroxidation and nigrostriatal neurodegeneration in vivo. Brain Res. 698, 285-287.
68. 68. Tampo Y. and Yonaha M. (1992) Antioxidant mechanism of Mn(II) in phospholipid peroxidation. Free Rad. Biol. Med. 13, 115-120.
69. 2+ injection. J. Neurochem. 42, 976-980.
70. 2+-dependent lipid peroxidation by manganese. Int. J. Biochem. 20, 591-594.
71. 71. Wang J.-D., Huang C-C., Hwang Y.-H., Chiang J.-R., Lin J.-M. and Chen J.-S. (1989) Manganese-induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromaneanese smelter. Br. J. indust. Med. 46, 856-859.
72. 72. Watt F. and Grime G. W. (1994) Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microdialysis. J. Neurochem. 62, 134-146.
73. 73. Yamada M., Ohno S., Okayasu I., Okeda R., Hatakeyama S., Watanabe H., Ushio K. and Tsukagoshi H. (1986) Chronic manganese poisoning: a neuropathological study with determination of manganese in the brain. Acta neuropath. 70, 273-278.
74. 74. Yong V. W., Perry T. L., Goldolphin W. J., Jones K. A., Calavier R. M., Ito M. and Foulks J. G. (1986) Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons. Neuroloxicology 7, 19-24.
75. 75. Youdim M. B. and Riederer P. (1993) The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J. neural Transm. 40 Suppl., 57-67.